Cargando…
Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence
International guidelines on the treatment of bronchiectasis indicate that the use of inhaled antibiotics is effective, especially in symptomatic chronic bronchial infection (CBI) due to Pseudomonas aeruginosa (PA). To date, however, no such treatment has been approved by regulatory agencies. Of the...
Autores principales: | de la Rosa-Carrillo, David, Suárez-Cuartín, Guillermo, Golpe, Rafael, Máiz Carro, Luis, Martinez-Garcia, Miguel Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759979/ https://www.ncbi.nlm.nih.gov/pubmed/36540105 http://dx.doi.org/10.2147/IDR.S318173 |
Ejemplares similares
-
Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium
por: Collie, David, et al.
Publicado: (2015) -
Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review
por: de la Rosa-Carrillo, David, et al.
Publicado: (2023) -
Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
por: Oscullo, Grace, et al.
Publicado: (2023) -
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
por: Uttley, Lesley, et al.
Publicado: (2013) -
Ease of use of tobramycin inhalation powder compared with nebulized
tobramycin and colistimethate sodium: a crossover study in cystic fibrosis
patients with pulmonary Pseudomonas aeruginosa
infection
por: Greenwood, James, et al.
Publicado: (2017)